Home › Trial NCT03327285
C-CAR011 Treatment in Subjects With ALL After HSCT
- Trial IDNCT03327285
- StatusUnknown
- PhaseN/A
- Study typeInterventional
- SponsorPeking University People's Hospital
- Enrollment40
- Start date2018-03-01
- ConditionsAcute Lymphoblastic Leukemia(ALL)
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.